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Background. Sirtuin 1, encoded by the SIRT1 gene, is an emerging modulator of carbohydrate 
and lipid metabolism and may also influence the differentiation of bone cells.  
Aim. Our objective was to test the hypothesis that polymorphisms of SIRT1 are associated with 
body mass index (BMI) and bone mineral density (BMD).   
Methods. Cross-sectional genetic association study, with genotyping of 10 single nucleotide 
polymorphisms of the SIRT1 region. The discovery cohort included 1394 individuals (342 men, 
1052 women). Significant results were replicated in an independent cohort of 408 men.  
Results. We did not find a significant association of genotypes with BMD. There were no 
significant BMI differences across genotypes in women either. However, in men, two 
polymorphisms tended  to be  associated with BMI in the discovery cohort (p=0.03 and 0.05). A 
similar trend was also observed in the replication cohort. Thus, in the combined analysis of both 
cohorts men with C alleles at the rs12049646 locus had a lower BMI than TT homozygotes, with 
a mean difference of 0.82 kg/m
2
 (95 % confidence interval 0.15-1.48; p=0.016). Differences in 
the DNA binding of nuclear proteins between C and T alleles were also observed in vitro.  
Conclusions. These results suggest that common variants of the SIRT1 gene influence BMI but 
not BMD.  
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Sirtuins deacetylate several histones and transcription factors, such as the ones encoded by 
NFKB1, FOXO, PPARG, PPARGC1A and NF-B(1;2). Sirtuin 1, encoded by the SIRT1 gene 
located on human chromosome 10q21.3, facilitates lipolysis in the adipose tissue, modulates the 
differentiation of adipocyte precursors, regulates fatty acid oxidation in the liver, and influences 
insulin secretion  and resistance and the sensing of nutrient availability by the hypothalamus (3-
7). 
 There is increasing evidence of interaction between bone, energy metabolism and adipose tissue 
(8;9). In fact, sirtuins may differentially drive the differentiation of mesenchymal precursors 
towards either the osteoblast or the adipocytic lineage, both in vitro and in vivo (10). 
Resveratrol, a natural inducer  of the  SIRT1 gene, promotes osteogenesis by inducing RUNX2 
transcription (11) and inhibits osteoclast differentiation by interacting with the RANKL-NF-B 
pathway (12;13). 
Adiposity and bone mineral density (BMD)  have a strong genetic component and hereditary 
factors explain about 50-80% of the interindividual variance (14;15). Genome-wide and 
candidate gene studies have identified several loci clearly associated with these phenotypes, but 
those loci only explain a small proportion of the interindividual variation in bone and body mass 
(15-17). Therefore, many more loci remain to be discovered. Since sirtuin 1 plays an important 
role as a metabolic regulator, we planned this study to check the hypothesis that common 
polymorphisms of SIRT1 are associated with body mass index (BMI) and BMD.    
 
 4 
SUBJECTS AND METHODS 
Subjects.- We designed a cross-sectional genetic association study, with replication of 
significant results in an independent group and in vitro studies of allelic differences in the 
binding of nuclear proteins.   
The discovery cohort included 1394 Caucasians (342 men and 1052 women) from Cantabria, a 
region in Northern Spain, as previously described (18;19). All were interviewed by a physician 
to exclude drugs or diseases known to affect bone metabolism, such as hyperthyroidism, 
hyperparathyroidism, Cushing syndrome, immobilization, type I diabetes and other severe 
diseases (heart failure, chronic obstructive lung disease, malabsorption, liver disease, cancer, 
etc.). Body weight and height were measured by standard procedures and rounded to the nearest 
integer. Hip BMD was measured by DXA (Hologic).    
The replication group included 408 males over 50 years of age living in Valladolid, a province in 
Central Spain. They were selected from the Hortega cohort, a general population sample 
extracted from the Valladolid area to study cardiovascular risk factors (20).  
The study was approved by the Clinical Research Ethical Committees and informed consent was 
obtained from the participants. 
Genotyping.- Single nucleotide polymorphisms (SNPs) were analyzed in blood DNA by using 
specific primers and Taqman probes (Taqman genotyping assays, Applied Biosystems, Foster 
City, CA).   Tagger software (http://www.broadinstitute.org/mpg/tagger/) was used to select tag 
SNPs in the SIRT1 region plus 0.5kb downstream,  and 30 Kb upstream (NCBI Build 35/UCSC 
hg17), with a minor allele frequency >5% in the Caucasian population and r
2
>1 as criteria. In 
addition, rs3740051 was also genotyped because bioinformatic analysis suggested that it 
included a putative transcription factor binding site. SNPs showing evidence for association in 
the discovery cohort were selected to be analyzed in the replication cohort. 
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Gene expression and Electrophoretic Mobility Shift Assays (EMSA).- To study SIRT1 
expression in bone, trabecular bone samples were obtained from the central part of the femoral 
heads of patients subjected to hip replacement because of osteoporotic hip fractures (n=8) or 
controls with hip osteoarthritis (n=10). RNA was isolated with Trizol (Invitrogen, Carlsbad, CA, 
USA), and further purified by using a column adsorption procedure (Qiagen, Hilden, Germany). 
Aliquots of RNA (250 ng) were reverse-transcribed with the Superscript III kit (Invitrogen) and 
quantified by real-time PCR in an ABI7300 apparatus (Applied Biosystems), using specific 
primers and  FAM-labelled probes for SIRT1 (Taqman gene expression assays, Applied 
Biosystems). The results were then normalized to the expression of the housekeeping gene 
TATA box binding protein (TBP), as previously published (21;22). 
Double-stranded  oligonucleotides with the sequences including the region of the rs12049646 
polymorphism (TATATTGGTCTCGTTGGGATGTTC and 
TATATTGGTCTTGTTGGGATGTTC) were used to determine the binding of C and T alleles 
respectively by EMSA. The forward oligonucleotides (the ones shown) were labelled in 5’ with 
IRDye700 (Li-Cor Biosciences, Lincoln, NE) during the synthesis. The preparation of nuclear 
extracts and the electrophoresis procedures have been described previously (23). For the 
competition experiments, an excess of C allele oligonucleotide was added to the mix prior to the 
addition of the labelled oligonucleotide. The bands were quantified in an Odyssey Infrared 
Imaging System (Li-Cor Biosciences, Lincoln, NE). The inverse of band intensity versus the 
excess of unlabeled oligonucleotide was represented and the slope of the resulting straight line 
was inversely proportional to the affinity of each allele for the proteins in the nuclear extract. 
Statistical analysis.- The sample size was considered enough to have >90% power to detect 
genetic effects explaining at least a 1% of the phenotype variance (estimated with Quanto 
software, available at http://hydra.usc.edu/gxe/). The departure from Hardy-Weinberg 
equilibrium (HWE) was tested with Plink software (24). The Haplotypic blocks were estimated 
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by the Gabriel method, implemented in Haploview (25). The results were adjusted by potential 
confounding variables (age and weight) by ANCOVA or multiple linear regression. The results 
in different cohorts were combined by computing the mean difference with MIX software (26). 
The manuscript was elaborated taking into consideration the STREGA recommendations (27). 
 
RESULTS 
The genotype frequency distributions were consistent with HWE (p>0.3). All SNPs were 
grouped into a single haplotypic block (figure 1).  
The characteristics of study subjects are shown in table 1. In women there was no evidence for 
association between the genotypes and either BMI or BMD (table 2). 
However, men with the minor C alleles at the rs12049646 locus have a lower BMI (p=0.0328 
under an additive model and 0.0296 under a dominant model). Likewise, those with G alleles at 
the neighbour locus rs3740051  tended to have a lower BMI, close to the statistical significance 
(p=0.0545 under an additive model and 0.050 under a dominant model) (table 2). Similar results 
were observed in the haplotypic analysis. In multilocus models, only  rs12049646 showed a 
significant independent effect. We found no association between the polymorphisms and BMD. 
Similar results were obtained in age-adjusted analyses (not shown).  
Given the potential effects of sirtuins on bone cell differentiation, we also measured SIRT1 
messenger RNA in bone. SIRT1 expression was detected in all bone samples studied. The 
expression level was similar in samples from patients with fractures and in controls with 
osteoarthritis (3.4±3.9 relative units  in fractures vs. 2.6±1.6 in controls; p=0.8; figure 2). 
The association of rs12049646 and BMI was tested in a separate group of men, the population-
based Hortega cohort. In this group we found a similar trend for association between rs12049646 
alleles and BMI that was not statistically significant (p=0.266; figure 3). However, a relationship 
between the genotypes and BMI was confirmed in the combined analysis of both cohorts. In 
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comparison with TT homozygotes, men with C alleles at the rs12049646 locus had lower BMI, 
with an averaged mean difference of 0.82 kg/m
2
 (95 % confidence interval 0.15-1.48; p=0.016) 
(figure 3). 
In order to confirm the potential regulatory role of the rs12049646 polymorphism, we studied 
the binding of nuclear proteins to both alleles by EMSA. As seen in figure 3, C alleles  showed 
stronger binding properties than T alleles. In competition experiments with increasing amounts 
of  unlabeled C allele oligonucleotide,  the T allele oligonucleotide was more easily displaced 
from the complex when an excess of an unlabeled C oligonucleotide was used (figure 4). Taken 
together, the results indicated that the C to T change results in a reduced protein binding ability. 
 
DISCUSSION 
Body size, adiposity and bone mass have a strong genetic component. Incompletely elucidated 
interactions exist between these phenotypes. Several adipokines and hormones (including 
estrogens) synthesized in the adipose tissue may have effects on bone remodelling.  It is also 
possible that  common genetic factors influence both bone and body mass (28;29).   
Sirtuins play an important role in energy metabolism regulation, and some experimental data 
also suggest an influence on bone remodelling. Therefore, we hypothesized that genetic variants 
of SIRT1 might be associated with differences in body and bone mass. The whole SIRT1 region 
is in strong linkage disequilibrium and in fact all the SNPs included in this study belong to a 
single haplotypic block. We could not find evidence for association between SIRT1 
polymorphisms and BMD. Thus, our data argue against an important influence of allelic variants 
of the SIRT1 gene on bone mass. Additionally, no differences in SIRT1 expression were found 
between patients with fragility hip fractures and controls. Given the sample size in the discovery 
cohort, our study had 75% and 99% power (in men and women, respectively) to detect an allelic 
influence explaining at least 2% of BMD variation. However, the existence of allelic variants 
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with smaller effects on BMD, or of rare variants with more important effects, cannot be 
excluded, particularly in men. For instance, the estimated power to detect a genetic effect 
explaining 0.5% of BMD variance was 26% in men and 46% in women. 
On the other hand, a polymorphism located in the 5’ region of SIRT1 was associated with BMI 
in men. There was a consistent trend for the minor C alleles to be associated with lower BMI in 
the two cohorts studied, reaching the conventional threshold for statistical significance in one of 
them and in the combined analysis. The rs12049646 polymorphism is located 20 kb upstream 
the translation start site. It could modulate SIRT1 transcription by influencing the binding of 
transcription factors or other regulatory molecules. In support of this notion, we found allele-
specific differences in the binding of nuclear proteins in vitro. A bioinformatic analysis using 
MatInspector software (www.genomatix.de) revealed potential differences in the binding of 
some steroid hormone receptors. However, further experiments are needed to elucidate the 
transcription factors actually involved, as well as to confirm if an interaction between sex 
hormones and sirtuin 1 actually exists, which could explain the sex-related differences in the 
association between SIRT1 polymorphisms and BMI. Whatever the molecular explanation 
relating SNPs and gene transcription might be, differences in sirtuin expression may influence 
energy metabolism by several mechanisms, including the regulation of adipocyte differentiation 
and function (3;4;30) and energy expenditure (31;32).  
Genome-wide association studies (GWAS) have revolutionized the search of the genetic factors 
involved in obesity and other complex disorders. However, in a large collaborative analysis of 
GWAS results, SIRT1 was not pointed as a gene associated with BMI (17). Likewise, the  
GWAS catalog (www.genome.gov/gwastudies) does not include any study showing a significant 
association between SIRT1 polymorphisms and BMI.  However, it does not exclude an influence 
of SIRT1 variants on BMI. Sample size, inclusion of heterogeneous groups of patients and other 
factors may limit the power of GWAS to identify some genes truly related to the phenotype 
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studied. In fact, although  GWAS have lead to the discovery of many genes not previously 
known to be associated with BMI,  the proportion of the phenotypic variation explained by those 
genes is still very small. This indicates that much more research is needed to identify other gene 
variants and novel genes explaining the “missing heritability”. Our results suggest that SIRT1 
may be one of those genes, at least in male individuals.  
Genetic association studies are prone to false-positive results derived from population 
stratification and other factors. The association between rs12049646 and BMI found in this study 
would not be statistically significant after multiple-test adjustment. However, we regarded it as 
likely real because it remained significant in the combined analysis of two independent cohorts 
and in vitro data were consistent with allelic differences in the binding of transcription factors. 
Data from other investigators also suggest an association between SIRT1 polymorphisms and 
adipose tissue mass. Zillikens reported an association of alleles of the noncoding rs7895833 
(also included in our study) and rs1467568 polymorphisms with BMI in the Dutch population 
(33). Van den Berg found an association of alleles at the synonymous SNP rs2273773 with BMI 
in other Dutch cohort (34). In a case-control study, Peeters genotyped two SNPs of the SIRT1 
gene and found an association of the intronic polymorphism rs7069102 with obesity (35). An 
association between several SIRT1 polymorphisms and BMI has also been recently reported in 
French and Swedish individuals (36). Likewise, in line with our results, a recent Japanese study 
found several polymorphisms associated with BMI in males, but not in females (37). On the 
other hand, an association between genetic variants of SIRT1 and energy expenditure was 
reported in a German study (38). Overall, these studies suggest an association of variants of the 
SIRT1 gene with adipose tissue mass and obesity. However, given the strong linkage in the 
region, it is hard to know which polymorphisms are actually responsible for the association. 
Deep-sequencing analyses of the whole region followed by further functional in vitro studies 
would be  needed to elucidate the allelic variants actually responsible for the association. 
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In conclusion, this study suggests that some common variants of the SIRT1 gene influence body 
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Age, yr 67±7 67±9 70±11 
Height, cm 167±6 155±6 166±7 
Weight, kg 80±11 68±12 76±11 
BMI, kg/m
2 
28.7±3.4 28.3±4.6 27.4±3.5 
Type 2 diabetes, % 14 18 16 




  Polymorphisms studied and association of genotypes and phenotypes in the discovery cohort. 
 
 
   
p-values for 
association in females 
p-values for 






MAF BMD BMI BMD BMI 
rs7895833 5’ G 0.21 0.66 0.95 0.59 0.99 
rs17712705 5’ A 0.32 0.76 0.70 0.42 0.39 
rs12049646 5’ C 0.06 0.72 0.28 0.42 0.03 
rs12778366 5’ C 0.12 0.73 0.46 0.65 0.39 
rs3740051 5’ G 0.06 0.79 0.23 0.49 0.05 
rs10997860 Intron T 0.33 0.91 0.53 0.27 0.57 
rs12413112 Intron A 0.12 0.88 0.53 0.52 0.79 
rs10997866 Intron A 0.35 0.69 0.62 0.29 0.78 
rs2224573 Intron A 0.35 0.97 0.70 0.29 0.72 
rs10823111 Intron T 0.33 0.86 0.50 0.29 0.53 
MAF: minor allele frequency 
BMD: bone mineral density; BMI, body mass index 







Figure 1. Linkage disequilibrium between SIRT1 polymorphisms. The numbers represent the D’ 
distances (x100). 
 
Figure 2. Sirtuin 1 gene expression in bone samples from patients with osteoporotic hip fractures 
and controls. 
 
Figure 3.  Differences in BMI between men with and without C alleles at the rs12049646 locus 
in the discovery and replication cohorts.  
 
Figure 4. Differences in the binding of nuclear proteins to rs12049646 alleles. A). Competitive 
EMSA’s showing the differences in the protein binding ability as a consequence of the C to T 
change. Nuclear extracts were mixed with fluorescent oligonucleotides corresponding to either 
allele (the six lanes on the left correspond to the C allele and the six  lanes on the right to the T 
allele) and competed with increasing amounts of unlabeled C- specific oligonucleotide. NE, no 
nuclear extract added to the reaction; the lanes labelled C and T indicated that no competitor was 
present; X10, X25 and X50 indicated an excess of 10, 25 or 50 fold of the unlabeled C- specific 
oligonucleotide. The specific bands are marked with arrows. B) Representation of the inverse of 
the upper band intensity versus unlabeled oligonucleotide excess. The slope of the line is 
inversely related to the protein binding ability of the oligonucleotide. 
 
